Incidence of severe myositis in patients treated with lipid-lowering drugs

被引：0
|
作者：
Kim, Ju Young
Park, Byung Joo
机构：
[1] Seoul Natl Univ, Bundang Hosp, Songnam, Gyeonggi Do, South Korea
[2] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2006年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
537
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [21] Lipid-lowering drugs and cataract
    Bezin, J.
    Mansiaux, Y.
    Pariente, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 6 - 6
  • [22] Choice of lipid-lowering drugs
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1998, 40 (1042): : 117 - 122
  • [23] Pharmacogenetics of lipid-lowering drugs
    Kivisto, K. T.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 : 47 - 47
  • [24] Rhabdomyolysis and lipid-lowering drugs
    Tenenbaum, A
    Fisman, EZ
    Motro, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (12): : 1448 - 1448
  • [25] Lipid-lowering drugs and homocysteine
    Landray, MJ
    Townend, JN
    Martin, S
    Martin, U
    Wheeler, DC
    LANCET, 1999, 353 (9168): : 1974 - 1975
  • [26] Carcinogenicity of lipid-lowering drugs
    Newman, TB
    Hulley, SB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (01): : 55 - 60
  • [27] Lipid-Lowering Drugs and Cataract
    Bezin, Julien
    Mansiaux, Yohann
    Pariente, Antoine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 555 - 555
  • [28] INDICATIONS FOR LIPID-LOWERING DRUGS
    DAVIGNON, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 : S3 - S10
  • [29] Lipid-lowering drugs and homocysteine
    de Lorgeril, M
    Salen, P
    Paillard, F
    Lacan, P
    Richard, G
    LANCET, 1999, 353 (9148): : 209 - 210
  • [30] AN OVERVIEW OF LIPID-LOWERING DRUGS
    ILLINGWORTH, DR
    DRUGS, 1988, 36 : 63 - 71
12345